FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2932483923> ?p ?o ?g. }

• W2932483923 endingPage "260" @default.
• W2932483923 startingPage "251" @default.
• W2932483923 abstract "Chronic kidney disease (CKD) is a frequent complication of type 2 diabetes mellitus (T2DM) and is associated with poor clinical outcomes, including an increased risk of all-cause and cardiovascular mortality, as well as adverse economic and social effects. Slowing the development and progression of CKD remains an unmet clinical need in patients with T2DM. Sodium-glucose co-transporter 2 (SGLT2) inhibitors are widely used for the management of T2DM and have effects beyond glucose lowering that include cardiovascular benefits and potential renoprotective effects. Although the glucose-lowering efficacy of these agents is dependent on renal function, the cardiovascular and renal benefits of SGLT2 inhibition appear to be maintained to estimated glomerular filtration levels as low as 30 mL/min/1.73 m2. Clinical evidence has indicated that these agents can reduce the risk of development or worsening of albuminuria, a marker of renal damage, through a range of mechanisms. These include blood pressure lowering, reduction of intraglomerular pressure and hyperfiltration, modification of inflammatory processes, reduction of ischemia-related renal injury, and increases in glucagon levels. The blood pressure-lowering effect of SGLT2 inhibitors is maintained in people with CKD and could further contribute to reduced renal burden, as well as potentially offering synergistic effects with antihypertensive therapies in these patients. Several cardiovascular outcomes trials (CVOTs) have included renal endpoints, adding to the growing evidence of the potential renoprotective effects of these agents in patients with T2DM. Several ongoing dedicated renal outcomes trials will provide further guidance on the potential clinical role of SGLT2 inhibitors in slowing the development and progression of renal impairment in individuals with T2DM." @default.
• W2932483923 created "2019-04-11" @default.
• W2932483923 creator A5081667069 @default.
• W2932483923 date "2019-04-14" @default.
• W2932483923 modified "2023-10-17" @default.
• W2932483923 title "SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence" @default.
• W2932483923 cites W1968145432 @default.
• W2932483923 cites W1977520942 @default.
• W2932483923 cites W1981055539 @default.
• W2932483923 cites W1983085727 @default.
• W2932483923 cites W1990025047 @default.
• W2932483923 cites W1997900205 @default.
• W2932483923 cites W2026412750 @default.
• W2932483923 cites W2030192134 @default.
• W2932483923 cites W2035868046 @default.
• W2932483923 cites W2036936011 @default.
• W2932483923 cites W2038348179 @default.
• W2932483923 cites W2044904729 @default.
• W2932483923 cites W2045790951 @default.
• W2932483923 cites W2072040765 @default.
• W2932483923 cites W2075044961 @default.
• W2932483923 cites W2077636750 @default.
• W2932483923 cites W2082511677 @default.
• W2932483923 cites W2107031719 @default.
• W2932483923 cites W2107146663 @default.
• W2932483923 cites W2113285066 @default.
• W2932483923 cites W2113507924 @default.
• W2932483923 cites W2114598208 @default.
• W2932483923 cites W2118613762 @default.
• W2932483923 cites W2125743309 @default.
• W2932483923 cites W2130570549 @default.
• W2932483923 cites W2131572546 @default.
• W2932483923 cites W2134304394 @default.
• W2932483923 cites W2138173919 @default.
• W2932483923 cites W2146264128 @default.
• W2932483923 cites W2148513135 @default.
• W2932483923 cites W2152413054 @default.
• W2932483923 cites W2153839551 @default.
• W2932483923 cites W2154525074 @default.
• W2932483923 cites W2187514862 @default.
• W2932483923 cites W2202866687 @default.
• W2932483923 cites W2424539745 @default.
• W2932483923 cites W2436309489 @default.
• W2932483923 cites W2495583055 @default.
• W2932483923 cites W2509810128 @default.
• W2932483923 cites W2553261268 @default.
• W2932483923 cites W2599491691 @default.
• W2932483923 cites W2623598563 @default.
• W2932483923 cites W2626446274 @default.
• W2932483923 cites W2733849831 @default.
• W2932483923 cites W2766605127 @default.
• W2932483923 cites W2766754230 @default.
• W2932483923 cites W2769581384 @default.
• W2932483923 cites W2770821084 @default.
• W2932483923 cites W2772844083 @default.
• W2932483923 cites W2793355388 @default.
• W2932483923 cites W2797653434 @default.
• W2932483923 cites W2800723402 @default.
• W2932483923 cites W2804805813 @default.
• W2932483923 cites W2808725516 @default.
• W2932483923 cites W2808915250 @default.
• W2932483923 cites W2809632141 @default.
• W2932483923 cites W2890465901 @default.
• W2932483923 cites W2897993744 @default.
• W2932483923 cites W2900413769 @default.
• W2932483923 cites W2916996193 @default.
• W2932483923 cites W2917653738 @default.
• W2932483923 cites W4212810717 @default.
• W2932483923 cites W4254631170 @default.
• W2932483923 doi "https://doi.org/10.1080/00325481.2019.1601404" @default.
• W2932483923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30929540" @default.
• W2932483923 hasPublicationYear "2019" @default.
• W2932483923 type Work @default.
• W2932483923 sameAs 2932483923 @default.
• W2932483923 citedByCount "53" @default.
• W2932483923 countsByYear W29324839232019 @default.
• W2932483923 countsByYear W29324839232020 @default.
• W2932483923 countsByYear W29324839232021 @default.
• W2932483923 countsByYear W29324839232022 @default.
• W2932483923 countsByYear W29324839232023 @default.
• W2932483923 crossrefType "journal-article" @default.
• W2932483923 hasAuthorship W2932483923A5081667069 @default.
• W2932483923 hasBestOaLocation W29324839231 @default.
• W2932483923 hasConcept C126322002 @default.
• W2932483923 hasConcept C134018914 @default.
• W2932483923 hasConcept C159641895 @default.
• W2932483923 hasConcept C177713679 @default.
• W2932483923 hasConcept C2776174234 @default.
• W2932483923 hasConcept C2776179406 @default.
• W2932483923 hasConcept C2777180221 @default.
• W2932483923 hasConcept C2778653478 @default.
• W2932483923 hasConcept C2779134260 @default.
• W2932483923 hasConcept C2779922275 @default.
• W2932483923 hasConcept C2910068830 @default.
• W2932483923 hasConcept C535046627 @default.
• W2932483923 hasConcept C555293320 @default.
• W2932483923 hasConcept C71924100 @default.
• W2932483923 hasConcept C84393581 @default.

• next